Medical education and the pharmaceutical industry

Perspectives in Biology and Medicine

Volumn 50, Issue 1, 2007, Pages 32-39

  Goodman, Robert L ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ATTITUDE; CONFLICT; CURRICULUM; DRUG INDUSTRY; MEDICAL EDUCATION; MEDICAL SCHOOL; PEER GROUP; POLICY; PRIORITY JOURNAL; REVIEW;

EID: 33846638704     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2007.0005     Document Type: Review

References (25)

1. Accreditation Council for Graduate Medical Education (ACGME). 2002. Principles to guide the relationship between graduate medical education and industry, http:// www.acgme.org.
2. Adair, R. F., and L. R. Holmgren. 2005. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med 118(8):881-84.
3. Agrawal, S., I. Saluja, and J. A. Kaczorowski. 2004. Prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med 79(11):1046-50.
4. American Medical Association (AMA). 2001. Opinion of the Council on Ethical and Judicial Affairs E-8.061: gifts to physicians from industry, http://www.ama-assn.org/ ama/pub/category/4001.html.
5. American Medical Student Association (AMSA). 2002. Principles regarding pharmaceuticals and medical devices. http://www.amsa.org/about/ppp/pharm.cfm.
6. Avorn, J., M. Chen, and R. Hartley. 1982. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 73(1):4-8.
7. Brett, A. S., W. Burr, and J. Moloo. 2003. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 163(18):2213-18.
8. Caudill, T. S., et al. 1996. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 5(4):201-6.
9. Friedman, M. 1962. Capitalism and freedom. Chicago: Univ. of Chicago Press.
10. Friedman, M. 1975. There's no such thing as a free lunch. LaSalle, IL: Open Court.
11. Hafferty, F. W., and R. Franks. 1994. The hidden curriculum, ethics teaching, and the future of medical education. Acad Med 69:861-71.
12. Hodges, B. 1995. Interactions with the pharmaceutical industry: Experiences and attitudes of psychiatry residents, interns and clerks. CMAJ 153(5):553-59.
13. Kassirer J. P. 2007. Professional societies and industry support: What is the quid pro quo? Perspect Biol Med 50(1):7-17.
14. Lichstein, P. R., R. C. Turner, and K. O'Brien. 1992. Impact of pharmaceutical company representatives on internal medicine residency programs: A survey of residency program directors. Arch Intern Med 152(5):1009-13.
15. Lurie, P., et al. 2005. Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting. J Public Health Policy 26(4):389-99.
16. McCormick, B. B., et al. 2001. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 286(16):1994-99.
17. Schneider, J. A., et al. 2006. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med 81(7): 595-602.
18. Sierles, F S., et al. 2005. Medical students' exposure to and attitudes about drug company interactions: A national survey. JAMA 294(9):1034-42.
19. Sigworth, S. K., M. D. Nettleman, and G. M. Cohen. 2001. Pharmaceutical branding of resident physicians. JAMA 286:1024-25.
20. Steinman, M. A., M. G. Shlipak, and S.J. McPhee. 2001. Of principles and pens: Attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110:551-57.
21. Watkins, R. S., and R. A. Kimberly,Jr. 2004. What residents don't know about physician-pharmaceutical industry interactions. Acad Med 79(5):432-37.
22. Wilkes, M. S., and J. R. Hoffman. 2001. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 76(12):1271-77.
23. Wofford, J. L., and C. A. Ohl. 2005. Teaching appropriate interactions with pharmaceutical company representatives: The impact of an innovative workshop on student attitudes. BMC Med Educ 5(1):5.
24. Ziegler, M. G., P. Lew, and B. C. Singer. 1995. The accuracy of drug information from pharmaceutical sales representatives. JAMA 273(16):1296-98.
25. Zipkin, D. A., and M. A. Steinman. 2005. Interactions between pharmaceutical representatives and doctors in training: A thematic review. J Gen Intern Med 20(8):777-86.